Pelvic Inflammatory Disease Clinical Trial
Official title:
Clinical Promotion Research of Complex Treatment With TCM to Diagnosis and Treatment on Different Syndrome Types of Pelvic Inflammatory Disease Sequelae
The trial attempts to optimize, standardize and simplify the characteristic diagnosis and treatment program of the dominant diseases in our hospital-the sequelae of pelvic inflammatory disease, so as to make it suitable for clinical diagnosis and treatment in primary hospital.
Sequelae of pelvic inflammatory disease (SPID) is a common cause of chronic pelvic pain, ectopic pregnancy and infertility, which seriously affects the physical and mental health of the patients, quality of life and family happiness. Western medicine for pelvic inflammatory disease sequelae is still lack of effective treatment methods, traditional Chinese medicine treatment of this disease has a unique advantage, with broad prospects for development..Standardized diagnosis and treatment scheme of this project on the one hand, improve and optimize the sequelae of pelvic inflammatory disease, including according to the dialectical treatment of herbal medicine combined with TCM (traditional Chinese medicine enema, external application of Chinese medicine intervention treatment); on the other hand, to observe the clinical curative effect and adverse reaction of traditional Chinese medicine comprehensive treatment. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04723069 -
Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
|
Phase 2 | |
Recruiting |
NCT03391440 -
A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease
|
Phase 4 | |
Completed |
NCT01671280 -
Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)
|
N/A | |
Completed |
NCT00115388 -
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
|
N/A | |
Completed |
NCT01236131 -
The Role of Novel Organisms in Acute Endometritis
|
N/A | |
Completed |
NCT01160640 -
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
|
Phase 2 | |
Active, not recruiting |
NCT03994055 -
Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer
|
N/A | |
Completed |
NCT00871494 -
Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan
|
Phase 3 | |
Completed |
NCT00783419 -
Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
|
||
Completed |
NCT01799356 -
Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
|
Phase 4 | |
Recruiting |
NCT05408624 -
Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses
|
||
Completed |
NCT01241110 -
To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment
|
Phase 4 | |
Completed |
NCT00453349 -
A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease
|
Phase 3 | |
Recruiting |
NCT04234945 -
Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity
|
N/A | |
Recruiting |
NCT06360965 -
Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT05648747 -
Pelvic Inflammatory Disease in COVID-19 Era
|
||
Completed |
NCT01793584 -
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
|
N/A | |
Completed |
NCT01299259 -
Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease
|
N/A | |
Completed |
NCT03054402 -
First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845
|
Phase 1 | |
Active, not recruiting |
NCT03828994 -
Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II
|
N/A |